 | • レポートコード：QFJ1-3754 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、活性化部分トロンボプラスチン検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（光学技術試験、機械技術試験、電気化学技術試験）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・活性化部分トロンボプラスチン検査の市場動向 ・企業の競争状況、市場シェア ・活性化部分トロンボプラスチン検査の種類別市場規模と予測2016-2027（光学技術試験、機械技術試験、電気化学技術試験） ・活性化部分トロンボプラスチン検査の用途別市場規模と予測2016-2027（病院、診療所、その他） ・活性化部分トロンボプラスチン検査の北米市場規模2016-2027（アメリカ、カナダ） ・活性化部分トロンボプラスチン検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・活性化部分トロンボプラスチン検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・活性化部分トロンボプラスチン検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・活性化部分トロンボプラスチン検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Horiba、Bio-Rad、Takara Bio、Johnson & Johnson、Siemens、Abbott、BioMeriux、Thermo Fisher Scientific、Danaher、Carlyle Group、BD、Roche） ・結論 |
Activated Partial Thromboplastin Test is mainly used to measure coagulation cascade i.e. blood clotting which is mainly derived from the original form of test in which only phospholipids concentration of test was controlled.
Market Analysis and Insights: Global Activated Partial Thromboplastin Test Market
The global Activated Partial Thromboplastin Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Activated Partial Thromboplastin Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Activated Partial Thromboplastin Test market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Activated Partial Thromboplastin Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Activated Partial Thromboplastin Test market.
Global Activated Partial Thromboplastin Test Scope and Market Size
Activated Partial Thromboplastin Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Activated Partial Thromboplastin Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Optical Technology Test
Mechanical Technology Test
Electrochemical Technology Test
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Horiba
Bio-Rad
Takara Bio
Johnson & Johnson
Siemens
Abbott
BioMeriux
Thermo Fisher Scientific
Danaher
Carlyle Group
BD
Roche
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Activated Partial Thromboplastin Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Optical Technology Test
1.2.3 Mechanical Technology Test
1.2.4 Electrochemical Technology Test
1.3 Market by Application
1.3.1 Global Activated Partial Thromboplastin Test Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Activated Partial Thromboplastin Test Market Perspective (2016-2027)
2.2 Activated Partial Thromboplastin Test Growth Trends by Regions
2.2.1 Activated Partial Thromboplastin Test Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Activated Partial Thromboplastin Test Historic Market Share by Regions (2016-2021)
2.2.3 Activated Partial Thromboplastin Test Forecasted Market Size by Regions (2022-2027)
2.3 Activated Partial Thromboplastin Test Industry Dynamic
2.3.1 Activated Partial Thromboplastin Test Market Trends
2.3.2 Activated Partial Thromboplastin Test Market Drivers
2.3.3 Activated Partial Thromboplastin Test Market Challenges
2.3.4 Activated Partial Thromboplastin Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Activated Partial Thromboplastin Test Players by Revenue
3.1.1 Global Top Activated Partial Thromboplastin Test Players by Revenue (2016-2021)
3.1.2 Global Activated Partial Thromboplastin Test Revenue Market Share by Players (2016-2021)
3.2 Global Activated Partial Thromboplastin Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Activated Partial Thromboplastin Test Revenue
3.4 Global Activated Partial Thromboplastin Test Market Concentration Ratio
3.4.1 Global Activated Partial Thromboplastin Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Activated Partial Thromboplastin Test Revenue in 2020
3.5 Activated Partial Thromboplastin Test Key Players Head office and Area Served
3.6 Key Players Activated Partial Thromboplastin Test Product Solution and Service
3.7 Date of Enter into Activated Partial Thromboplastin Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Activated Partial Thromboplastin Test Breakdown Data by Type
4.1 Global Activated Partial Thromboplastin Test Historic Market Size by Type (2016-2021)
4.2 Global Activated Partial Thromboplastin Test Forecasted Market Size by Type (2022-2027)
5 Activated Partial Thromboplastin Test Breakdown Data by Application
5.1 Global Activated Partial Thromboplastin Test Historic Market Size by Application (2016-2021)
5.2 Global Activated Partial Thromboplastin Test Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Activated Partial Thromboplastin Test Market Size (2016-2027)
6.2 North America Activated Partial Thromboplastin Test Market Size by Type
6.2.1 North America Activated Partial Thromboplastin Test Market Size by Type (2016-2021)
6.2.2 North America Activated Partial Thromboplastin Test Market Size by Type (2022-2027)
6.2.3 North America Activated Partial Thromboplastin Test Market Size by Type (2016-2027)
6.3 North America Activated Partial Thromboplastin Test Market Size by Application
6.3.1 North America Activated Partial Thromboplastin Test Market Size by Application (2016-2021)
6.3.2 North America Activated Partial Thromboplastin Test Market Size by Application (2022-2027)
6.3.3 North America Activated Partial Thromboplastin Test Market Size by Application (2016-2027)
6.4 North America Activated Partial Thromboplastin Test Market Size by Country
6.4.1 North America Activated Partial Thromboplastin Test Market Size by Country (2016-2021)
6.4.2 North America Activated Partial Thromboplastin Test Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Activated Partial Thromboplastin Test Market Size (2016-2027)
7.2 Europe Activated Partial Thromboplastin Test Market Size by Type
7.2.1 Europe Activated Partial Thromboplastin Test Market Size by Type (2016-2021)
7.2.2 Europe Activated Partial Thromboplastin Test Market Size by Type (2022-2027)
7.2.3 Europe Activated Partial Thromboplastin Test Market Size by Type (2016-2027)
7.3 Europe Activated Partial Thromboplastin Test Market Size by Application
7.3.1 Europe Activated Partial Thromboplastin Test Market Size by Application (2016-2021)
7.3.2 Europe Activated Partial Thromboplastin Test Market Size by Application (2022-2027)
7.3.3 Europe Activated Partial Thromboplastin Test Market Size by Application (2016-2027)
7.4 Europe Activated Partial Thromboplastin Test Market Size by Country
7.4.1 Europe Activated Partial Thromboplastin Test Market Size by Country (2016-2021)
7.4.2 Europe Activated Partial Thromboplastin Test Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Activated Partial Thromboplastin Test Market Size (2016-2027)
8.2 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Type
8.2.1 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Type (2016-2027)
8.3 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Application
8.3.1 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Application (2016-2027)
8.4 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region
8.4.1 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Activated Partial Thromboplastin Test Market Size (2016-2027)
9.2 Latin America Activated Partial Thromboplastin Test Market Size by Type
9.2.1 Latin America Activated Partial Thromboplastin Test Market Size by Type (2016-2021)
9.2.2 Latin America Activated Partial Thromboplastin Test Market Size by Type (2022-2027)
9.2.3 Latin America Activated Partial Thromboplastin Test Market Size by Type (2016-2027)
9.3 Latin America Activated Partial Thromboplastin Test Market Size by Application
9.3.1 Latin America Activated Partial Thromboplastin Test Market Size by Application (2016-2021)
9.3.2 Latin America Activated Partial Thromboplastin Test Market Size by Application (2022-2027)
9.3.3 Latin America Activated Partial Thromboplastin Test Market Size by Application (2016-2027)
9.4 Latin America Activated Partial Thromboplastin Test Market Size by Country
9.4.1 Latin America Activated Partial Thromboplastin Test Market Size by Country (2016-2021)
9.4.2 Latin America Activated Partial Thromboplastin Test Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Activated Partial Thromboplastin Test Market Size (2016-2027)
10.2 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Type
10.2.1 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Type (2016-2027)
10.3 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Application
10.3.1 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Application (2016-2027)
10.4 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country
10.4.1 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Horiba
11.1.1 Horiba Company Details
11.1.2 Horiba Business Overview
11.1.3 Horiba Activated Partial Thromboplastin Test Introduction
11.1.4 Horiba Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.1.5 Horiba Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Details
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Activated Partial Thromboplastin Test Introduction
11.2.4 Bio-Rad Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.2.5 Bio-Rad Recent Development
11.3 Takara Bio
11.3.1 Takara Bio Company Details
11.3.2 Takara Bio Business Overview
11.3.3 Takara Bio Activated Partial Thromboplastin Test Introduction
11.3.4 Takara Bio Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.3.5 Takara Bio Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Activated Partial Thromboplastin Test Introduction
11.4.4 Johnson & Johnson Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Siemens
11.5.1 Siemens Company Details
11.5.2 Siemens Business Overview
11.5.3 Siemens Activated Partial Thromboplastin Test Introduction
11.5.4 Siemens Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.5.5 Siemens Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Activated Partial Thromboplastin Test Introduction
11.6.4 Abbott Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.6.5 Abbott Recent Development
11.7 BioMeriux
11.7.1 BioMeriux Company Details
11.7.2 BioMeriux Business Overview
11.7.3 BioMeriux Activated Partial Thromboplastin Test Introduction
11.7.4 BioMeriux Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.7.5 BioMeriux Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Activated Partial Thromboplastin Test Introduction
11.8.4 Thermo Fisher Scientific Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Danaher
11.9.1 Danaher Company Details
11.9.2 Danaher Business Overview
11.9.3 Danaher Activated Partial Thromboplastin Test Introduction
11.9.4 Danaher Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.9.5 Danaher Recent Development
11.10 Carlyle Group
11.10.1 Carlyle Group Company Details
11.10.2 Carlyle Group Business Overview
11.10.3 Carlyle Group Activated Partial Thromboplastin Test Introduction
11.10.4 Carlyle Group Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.10.5 Carlyle Group Recent Development
11.11 BD
11.11.1 BD Company Details
11.11.2 BD Business Overview
11.11.3 BD Activated Partial Thromboplastin Test Introduction
11.11.4 BD Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.11.5 BD Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Activated Partial Thromboplastin Test Introduction
11.12.4 Roche Revenue in Activated Partial Thromboplastin Test Business (2016-2021)
11.12.5 Roche Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Activated Partial Thromboplastin Test Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Optical Technology Test
Table 3. Key Players of Mechanical Technology Test
Table 4. Key Players of Electrochemical Technology Test
Table 5. Global Activated Partial Thromboplastin Test Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Activated Partial Thromboplastin Test Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Activated Partial Thromboplastin Test Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Activated Partial Thromboplastin Test Market Share by Regions (2016-2021)
Table 9. Global Activated Partial Thromboplastin Test Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Activated Partial Thromboplastin Test Market Share by Regions (2022-2027)
Table 11. Activated Partial Thromboplastin Test Market Trends
Table 12. Activated Partial Thromboplastin Test Market Drivers
Table 13. Activated Partial Thromboplastin Test Market Challenges
Table 14. Activated Partial Thromboplastin Test Market Restraints
Table 15. Global Activated Partial Thromboplastin Test Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Activated Partial Thromboplastin Test Market Share by Players (2016-2021)
Table 17. Global Top Activated Partial Thromboplastin Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activated Partial Thromboplastin Test as of 2020)
Table 18. Ranking of Global Top Activated Partial Thromboplastin Test Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Activated Partial Thromboplastin Test Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Activated Partial Thromboplastin Test Product Solution and Service
Table 22. Date of Enter into Activated Partial Thromboplastin Test Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Activated Partial Thromboplastin Test Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Activated Partial Thromboplastin Test Revenue Market Share by Type (2016-2021)
Table 26. Global Activated Partial Thromboplastin Test Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Activated Partial Thromboplastin Test Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Activated Partial Thromboplastin Test Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Activated Partial Thromboplastin Test Revenue Market Share by Application (2016-2021)
Table 30. Global Activated Partial Thromboplastin Test Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Activated Partial Thromboplastin Test Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Activated Partial Thromboplastin Test Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Activated Partial Thromboplastin Test Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Activated Partial Thromboplastin Test Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Activated Partial Thromboplastin Test Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Activated Partial Thromboplastin Test Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Activated Partial Thromboplastin Test Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Activated Partial Thromboplastin Test Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Activated Partial Thromboplastin Test Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Activated Partial Thromboplastin Test Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Activated Partial Thromboplastin Test Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Activated Partial Thromboplastin Test Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Activated Partial Thromboplastin Test Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Activated Partial Thromboplastin Test Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Activated Partial Thromboplastin Test Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Activated Partial Thromboplastin Test Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Activated Partial Thromboplastin Test Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Activated Partial Thromboplastin Test Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Activated Partial Thromboplastin Test Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Activated Partial Thromboplastin Test Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Activated Partial Thromboplastin Test Market Size by Country (2022-2027) & (US$ Million)
Table 62. Horiba Company Details
Table 63. Horiba Business Overview
Table 64. Horiba Activated Partial Thromboplastin Test Product
Table 65. Horiba Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 66. Horiba Recent Development
Table 67. Bio-Rad Company Details
Table 68. Bio-Rad Business Overview
Table 69. Bio-Rad Activated Partial Thromboplastin Test Product
Table 70. Bio-Rad Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 71. Bio-Rad Recent Development
Table 72. Takara Bio Company Details
Table 73. Takara Bio Business Overview
Table 74. Takara Bio Activated Partial Thromboplastin Test Product
Table 75. Takara Bio Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 76. Takara Bio Recent Development
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Activated Partial Thromboplastin Test Product
Table 80. Johnson & Johnson Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Siemens Company Details
Table 83. Siemens Business Overview
Table 84. Siemens Activated Partial Thromboplastin Test Product
Table 85. Siemens Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 86. Siemens Recent Development
Table 87. Abbott Company Details
Table 88. Abbott Business Overview
Table 89. Abbott Activated Partial Thromboplastin Test Product
Table 90. Abbott Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. BioMeriux Company Details
Table 93. BioMeriux Business Overview
Table 94. BioMeriux Activated Partial Thromboplastin Test Product
Table 95. BioMeriux Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 96. BioMeriux Recent Development
Table 97. Thermo Fisher Scientific Company Details
Table 98. Thermo Fisher Scientific Business Overview
Table 99. Thermo Fisher Scientific Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 100. Thermo Fisher Scientific Recent Development
Table 101. Danaher Company Details
Table 102. Danaher Business Overview
Table 103. Danaher Activated Partial Thromboplastin Test Product
Table 104. Danaher Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 105. Danaher Recent Development
Table 106. Carlyle Group Company Details
Table 107. Carlyle Group Business Overview
Table 108. Carlyle Group Activated Partial Thromboplastin Test Product
Table 109. Carlyle Group Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 110. Carlyle Group Recent Development
Table 111. BD Company Details
Table 112. BD Business Overview
Table 113. BD Activated Partial Thromboplastin Test Product
Table 114. BD Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 115. BD Recent Development
Table 116. Roche Company Details
Table 117. Roche Business Overview
Table 118. Roche Activated Partial Thromboplastin Test Product
Table 119. Roche Revenue in Activated Partial Thromboplastin Test Business (2016-2021) & (US$ Million)
Table 120. Roche Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Activated Partial Thromboplastin Test Market Share by Type: 2020 VS 2027
Figure 2. Optical Technology Test Features
Figure 3. Mechanical Technology Test Features
Figure 4. Electrochemical Technology Test Features
Figure 5. Global Activated Partial Thromboplastin Test Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Activated Partial Thromboplastin Test Report Years Considered
Figure 10. Global Activated Partial Thromboplastin Test Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Activated Partial Thromboplastin Test Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Activated Partial Thromboplastin Test Market Share by Regions: 2020 VS 2027
Figure 13. Global Activated Partial Thromboplastin Test Market Share by Regions (2022-2027)
Figure 14. Global Activated Partial Thromboplastin Test Market Share by Players in 2020
Figure 15. Global Top Activated Partial Thromboplastin Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activated Partial Thromboplastin Test as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Activated Partial Thromboplastin Test Revenue in 2020
Figure 17. Global Activated Partial Thromboplastin Test Revenue Market Share by Type (2016-2021)
Figure 18. Global Activated Partial Thromboplastin Test Revenue Market Share by Type (2022-2027)
Figure 19. North America Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Activated Partial Thromboplastin Test Market Share by Type (2016-2027)
Figure 21. North America Activated Partial Thromboplastin Test Market Share by Application (2016-2027)
Figure 22. North America Activated Partial Thromboplastin Test Market Share by Country (2016-2027)
Figure 23. United States Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Activated Partial Thromboplastin Test Market Share by Type (2016-2027)
Figure 27. Europe Activated Partial Thromboplastin Test Market Share by Application (2016-2027)
Figure 28. Europe Activated Partial Thromboplastin Test Market Share by Country (2016-2027)
Figure 29. Germany Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Activated Partial Thromboplastin Test Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Activated Partial Thromboplastin Test Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Activated Partial Thromboplastin Test Market Share by Region (2016-2027)
Figure 39. China Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Activated Partial Thromboplastin Test Market Share by Type (2016-2027)
Figure 47. Latin America Activated Partial Thromboplastin Test Market Share by Application (2016-2027)
Figure 48. Latin America Activated Partial Thromboplastin Test Market Share by Country (2016-2027)
Figure 49. Mexico Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Activated Partial Thromboplastin Test Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Activated Partial Thromboplastin Test Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Activated Partial Thromboplastin Test Market Share by Country (2016-2027)
Figure 55. Turkey Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Activated Partial Thromboplastin Test Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Horiba Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 59. Bio-Rad Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 60. Takara Bio Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 61. Johnson & Johnson Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 62. Siemens Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 63. Abbott Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 64. BioMeriux Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 66. Danaher Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 67. Carlyle Group Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 68. BD Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Activated Partial Thromboplastin Test Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の活性化部分トロンボプラスチン時間検査（APTT検査）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market The global Activated Partial Thromboplastin Time Testing (APTT Testing) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. W…- 世界のマスク適合性試験市場規模・現状・予測（2021年-2027年） Mask fit test can quickly complete the fit test of masks and other respirators to ensure that it provides good protection performance. Security experts will also formulate the best protection schemes and standard regulations based on the results of closeness experiments. It is widely used in hospita…
- 世界のHPV DNA検査市場規模・現状・予測（2021年-2027年） HPV DNA test is used to check for high-risk HPV infection in women. Market Analysis and Insights: Global HPV DNA Test Market The global HPV DNA Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accura…
- 世界のナトリウム利尿ペプチド検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Natriuretic Peptides Test Market The global Natriuretic Peptides Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
- 世界のB型ナトリウム利尿ペプチド検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-type Natriuretic Peptide Test Market The global B-type Natriuretic Peptide Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…